Reduced expression of claudin-1 was observed in patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) [38, 39], while an increase in claudin-2 was found in the inflamed epithelium of patients with ulcerative colitis (UC) [40, 41]. Here, CLDN2 is linked to ulcerative colitis.